JP2023535476A5 - - Google Patents
Info
- Publication number
- JP2023535476A5 JP2023535476A5 JP2023505826A JP2023505826A JP2023535476A5 JP 2023535476 A5 JP2023535476 A5 JP 2023535476A5 JP 2023505826 A JP2023505826 A JP 2023505826A JP 2023505826 A JP2023505826 A JP 2023505826A JP 2023535476 A5 JP2023535476 A5 JP 2023535476A5
- Authority
- JP
- Japan
- Prior art keywords
- zwitterion
- tautomer
- prodrug
- salt
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2011604.2 | 2020-07-27 | ||
| GBGB2011604.2A GB202011604D0 (en) | 2020-07-27 | 2020-07-27 | GLP-1 receptor antagonists |
| PCT/GB2021/051921 WO2022023723A1 (en) | 2020-07-27 | 2021-07-27 | Glp-1 receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023535476A JP2023535476A (ja) | 2023-08-17 |
| JP2023535476A5 true JP2023535476A5 (https=) | 2024-07-31 |
Family
ID=72339360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023505826A Pending JP2023535476A (ja) | 2020-07-27 | 2021-07-27 | Ｇｌｐ－１受容体アンタゴニスト |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230279053A1 (https=) |
| EP (1) | EP4188409A1 (https=) |
| JP (1) | JP2023535476A (https=) |
| CN (1) | CN116171283A (https=) |
| AU (1) | AU2021319051A1 (https=) |
| CA (1) | CA3190422A1 (https=) |
| GB (1) | GB202011604D0 (https=) |
| WO (1) | WO2022023723A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3204051A1 (en) | 2021-01-20 | 2022-07-28 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| JP7642830B2 (ja) | 2021-09-15 | 2025-03-10 | バイキング・セラピューティクス・インコーポレイテッド | 代謝及び肝臓障害の処置のための組成物及び方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201816639D0 (en) * | 2018-10-12 | 2018-11-28 | Heptares Therapeutics Ltd | GLP-1 Receptor Antagonist |
-
2020
- 2020-07-27 GB GBGB2011604.2A patent/GB202011604D0/en not_active Ceased
-
2021
- 2021-07-27 CN CN202180053052.3A patent/CN116171283A/zh active Pending
- 2021-07-27 US US18/017,693 patent/US20230279053A1/en active Pending
- 2021-07-27 EP EP21751858.8A patent/EP4188409A1/en active Pending
- 2021-07-27 JP JP2023505826A patent/JP2023535476A/ja active Pending
- 2021-07-27 AU AU2021319051A patent/AU2021319051A1/en active Pending
- 2021-07-27 WO PCT/GB2021/051921 patent/WO2022023723A1/en not_active Ceased
- 2021-07-27 CA CA3190422A patent/CA3190422A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102186881B (zh) | 胰高血糖素样肽-1衍生物及其应用 | |
| JP7642830B2 (ja) | 代謝及び肝臓障害の処置のための組成物及び方法 | |
| JP2023535476A5 (https=) | ||
| CN1202896A (zh) | 嘌呤衍生物及其制备方法 | |
| JP2022504798A5 (https=) | ||
| JP2906654B2 (ja) | 免疫抑制剤及びその製造方法 | |
| WO1996033212A1 (fr) | Nouveaux derives peptidiques | |
| CN101657453B (zh) | 作为PKC-θ抑制剂的嘌呤类 | |
| CN101679412A (zh) | 作为PKC-θ抑制剂的嘌呤酮类和1H-咪唑并吡啶酮类 | |
| US20150202218A1 (en) | Broad Spectrum Inhibitors of the Post Proline Cleaving Enzymes for Treatment of Hepatitis C Virus Infections | |
| EP2736909B1 (en) | Process for the preparation of sitagliptin and its pharmaceutically acceptable salts | |
| CN116655772A (zh) | 一种长效的glp-1/glp-2双激动剂化合物 | |
| JP5871905B2 (ja) | グルカゴン様ペプチド−１類似体およびその使用 | |
| WO2024178000A2 (en) | Polynucleotides encoding modified interleukin 2 (il2) polypeptides, and methods of making and using the same | |
| WO2012016419A1 (zh) | Glp-1衍生物及其应用 | |
| CN102203130B (zh) | Glp-1衍生物及其应用 | |
| CN105367572B (zh) | 一种制备作为二肽基肽酶‑4抑制剂的化合物的中间体 | |
| CN101395143A (zh) | 用于治疗疟疾或aids的氮杂杂环化合物 | |
| JPH10330398A (ja) | 新規環状ペプチド | |
| Chavan et al. | An overview of recent development towards the synthesis of Linagliptin a DPP-4 inhibitor. | |
| US20260015365A1 (en) | Prodrugs of somatostatin receptors subtype 4 (sstr4) agonists and their applications | |
| CN104478880B (zh) | 作为dpp-iv抑制剂的双胍衍生物 | |
| WO1998029118A1 (en) | Novel tripeptide compounds and anti-aids drugs | |
| CN105503873B (zh) | 一种作为二肽基肽酶‑4抑制剂的化合物的制备方法 | |
| CN104478879B (zh) | 一种作为二肽基肽酶-4抑制剂的化合物 |